BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29312569)

  • 61. Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXR
    Tai TS; Tien N; Shen HY; Chu FY; Wang CCN; Lu CH; Yu HI; Kung FP; Chuang HH; Lee YR; Chang HY; Lim YP
    Evid Based Complement Alternat Med; 2019; 2019():9401648. PubMed ID: 31976003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knockdown of ACOT4 alleviates gluconeogenesis and lipid accumulation in hepatocytes.
    Yuan Q; Zhang X; Yang X; Zhang Q; Wei X; Ding Z; Chen J; Hua H; Huang D; Xu Y; Wang X; Gao C; Liu S; Zhang H
    Heliyon; 2024 Mar; 10(5):e27618. PubMed ID: 38495177
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Serum Apolipoprotein A5 Concentration with Nonalcoholic Fatty Liver Disease in Ningbo, China.
    Liu X; Xu P; Tao X; Li W; Hong Q; Cao Q
    Contrast Media Mol Imaging; 2022; 2022():7015528. PubMed ID: 35854768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.
    Huang PP; Zhu WQ; Xiao JM; Zhang YQ; Li R; Yang Y; Shen L; Luo F; Dai W; Lian PA; Tang YX; Ran JL; Huang XS
    Front Pharmacol; 2022; 13():935362. PubMed ID: 36034782
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease.
    Gena P; Mastrodonato M; Portincasa P; Fanelli E; Mentino D; Rodríguez A; Marinelli RA; Brenner C; Frühbeck G; Svelto M; Calamita G
    PLoS One; 2013; 8(10):e78139. PubMed ID: 24205128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. X-box binding protein 1: A new metabolic mediator and drug target of metformin?
    Lou K; Sun P; Zhang C; Jiang Q; Pang S
    Front Pharmacol; 2022; 13():1013218. PubMed ID: 36438823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatic polypeptide nutrient solution improves high-cholesterol diet-induced rats with nonalcoholic fatty liver disease by activating AMP-activated protein kinase signaling pathway.
    Xiao Y; Wang J; Zhang Y; Zhang T; Qi X; Hou L; Ma Z; Xu F
    Food Sci Nutr; 2024 May; 12(5):3225-3236. PubMed ID: 38726419
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metformin Improves Comorbid Depressive Symptoms in Mice with Allergic Rhinitis by Reducing Olfactory Bulb Damage.
    Lv H; Gao Z; Wang Y; Chen S; Liu P; Xie Y; Guan M; Cong J; Xu Y
    Neurochem Res; 2023 Dec; 48(12):3639-3651. PubMed ID: 37574530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis.
    Chen Y; Jiang H; Zhan Z; Lu J; Gu T; Yu P; Liang W; Zhang X; Liu S; Bi H; Zhong S; Tang L
    Cell Death Dis; 2023 Feb; 14(2):85. PubMed ID: 36746922
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metformin: update on mechanisms of action on liver diseases.
    Ruan G; Wu F; Shi D; Sun H; Wang F; Xu C
    Front Nutr; 2023; 10():1327814. PubMed ID: 38192642
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Wen S; An R; Li ZG; Lai ZX; Li DL; Cao JX; Chen RH; Zhang WJ; Li QH; Lai XF; Sun SL; Sun LL
    Food Nutr Res; 2022; 66():. PubMed ID: 35757439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of theaflavin-3,3'-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota.
    Zhou C; Zhang W; Lin H; Zhang L; Wu F; Wang Y; Yu S; Peng X; Cheng W; Li M; Pan X; Huang Z; Zhang W
    Front Pharmacol; 2022; 13():925264. PubMed ID: 36105184
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Extract of Herbal Medicines Activates AMP-Activated Protein Kinase in Diet-Induced Obese Rats.
    Shin HY; Chung S; Kim SR; Lee JH; Seo HS; Shin YC; Ko SG
    Evid Based Complement Alternat Med; 2013; 2013():756025. PubMed ID: 23533517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD.
    Yue F; Shi Y; Wu S; Xing L; He D; Wei L; Qiu A; Russell R; Zhang D
    iScience; 2023 Dec; 26(12):108560. PubMed ID: 38089577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microarray analysis of mRNA expression profiles in liver of ob/ob mice with real-time atmospheric PM
    Lin L; Tian L; Li T; Sun M; Duan J; Yu Y; Sun Z
    Environ Sci Pollut Res Int; 2022 Nov; 29(51):76816-76832. PubMed ID: 35672633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reference Gene and Protein Expression Levels in Two Different NAFLD Mouse Models.
    Araujo LCC; Bordin S; Carvalho CRO
    Gastroenterol Res Pract; 2020; 2020():1093235. PubMed ID: 32089674
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advance of Metformin in Liver Disease.
    Bao J; Zhao Y; Xu X; Ling S
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38299294
    [TBL] [Abstract][Full Text] [Related]  

  • 78. AMPK-PPARγ-Cidec Axis Drives the Fasting-Induced Lipid Droplet Aggregation in the Liver of Obese Mice.
    Li H; Sun J; Li B; Jiang A; Tao J; Ning C; Li R; Liu H
    Front Nutr; 2022; 9():917801. PubMed ID: 35859752
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner.
    Chen Y; Jiang H; Zhan Z; Lu J; Gu T; Yu P; Liang W; Zhang X; Zhong S; Tang L
    J Pharm Anal; 2023 Nov; 13(11):1281-1295. PubMed ID: 38174118
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese
    Han J; Wysham WZ; Zhong Y; Guo H; Zhang L; Malloy KM; Dickens HK; Huh G; Lee D; Makowski L; Zhou C; Bae-Jump VL
    Oncotarget; 2017 Dec; 8(67):110965-110982. PubMed ID: 29340030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.